42+ Ivermectin Covid 19 Merck Venezuela. Kitasato university requested merck to conduct clinical trials in japan because they have priority for an expansion of ivermectin's indications, however merck declined. However, merck says its scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the.
Here is a reasonable description of what you can expect to happen next.
Nps medicinewise looks at the evidence so far. They will be testing what could be an effective dose of. The company stated in a press release that the immune responses were inferior to. For example, ray cited merck's recommendation against ivermectin as evidence of ineffectiveness, while merck used no evidence to support their claim.